Medicare Enrolled
Dr. Gabriella Gerstle, M.D.
Neurology · Boynton Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gerstle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gerstle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gerstle
Dr. Gabriella Gerstle is a neurology specialist in Boynton Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gerstle performed 2,104 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gerstle received a total of $21,990 from 62 pharmaceutical and/or device companies across 574 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gerstle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 20% volume in FL
$21,990 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 65866 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,104
Medicare services
Top 20% in FL for neurology
Not available
Unique patients (not deduplicated)
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
542 | $65 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
485 | $95 | $161 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
221 | $105 | $202 |
| Annual depression screening | 137 | $19 | $27 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
114 | $155 | $567 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
111 | $185 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
97 | $128 | $240 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 88 | $210 | $315 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
68 | $144 | $210 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
53 | $75 | $130 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
44 | $110 | $210 |
| New patient office visit, complex (60-74 min) | 41 | $166 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
36 | $145 | $290 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $95 | $150 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
11 | $89 | $150 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
11 | $103 | $145 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
11 | $9 | $15 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
11 | $39 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,990
Total received (2018-2024)
Avg $3,141/year across 7 years
Top 15% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
574
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,403
2023
$2,264
2022
$1,947
2021
$2,161
2020
$10,210
2019
$1,894
2018
$1,111
Payments by company (2024)
UCB, Inc.
$358
ABBVIE INC.
$230
Eisai Inc.
$230
EMD Serono, Inc.
$213
Alexion Pharmaceuticals, Inc.
$172
ARGENX US, INC.
$151
Amneal Pharmaceuticals LLC
$149
Biogen, Inc.
$132
CSL Behring
$106
ANI Pharmaceuticals, Inc.
$90
Otsuka America Pharmaceutical, Inc.
$88
Lilly USA, LLC
$81
LivaNova USA, Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$58
Novartis Pharmaceuticals Corporation
$58
ACADIA Pharmaceuticals Inc
$52
Alnylam Pharmaceuticals Inc.
$42
Acorda Therapeutics, Inc
$40
SK Life Science, Inc.
$33
Lundbeck LLC
$33
PFIZER INC.
$25
Top 3 companies account for 34.0% of 2024 payments
All-time payments by company (2018-2024) ›
SK Life Science, Inc.
$9,121
UCB, Inc.
$2,112
Amneal Pharmaceuticals LLC
$843
GENZYME CORPORATION
$834
EMD Serono, Inc.
$764
Novartis Pharmaceuticals Corporation
$739
Alexion Pharmaceuticals, Inc.
$628
Biogen, Inc.
$503
ARGENX US, INC.
$414
Eisai Inc.
$399
ACADIA Pharmaceuticals Inc
$398
US WorldMeds, LLC
$368
Teva Pharmaceuticals USA, Inc.
$352
Acorda Therapeutics, Inc
$343
ABBVIE INC.
$342
AstraZeneca Pharmaceuticals LP
$292
CSL Behring
$269
Supernus Pharmaceuticals, Inc.
$267
Lilly USA, LLC
$231
Otsuka America Pharmaceutical, Inc.
$222
Amgen Inc.
$219
AbbVie Inc.
$190
Kyowa Kirin, Inc.
$172
Genentech USA, Inc.
$163
Biohaven Pharmaceuticals, Inc.
$137
HARMONY BIOSCIENCES LLC
$117
Lundbeck LLC
$92
ANI Pharmaceuticals, Inc.
$90
LivaNova USA, Inc.
$87
Mallinckrodt Hospital Products Inc.
$86
Sunovion Pharmaceuticals Inc.
$84
Harmony Biosciences LLC
$82
Medtronic USA, Inc.
$81
EISAI INC.
$76
MDD US Operations, LLC
$68
Allergan, Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$58
AQUESTIVE THERAPEUTICS, INC.
$48
Upsher-Smith Laboratories LLC
$46
Neurelis, Inc.
$45
Alnylam Pharmaceuticals Inc.
$42
Neurocrine Biosciences, Inc.
$41
Abbott Laboratories
$40
ARBOR PHARMACEUTICALS, INC.
$38
Impax Laboratories, Inc.
$35
Janssen Pharmaceuticals, Inc
$33
CATALYST PHARMACEUTICALS, INC.
$31
Medtronic, Inc.
$26
Biohaven Pharmaceutical Holding Company Ltd.
$26
PFIZER INC.
$25
Corium, LLC
$24
BIOTRONIK INC.
$22
INSIGHTEC,INC
$21
Medtronic Vascular, Inc.
$19
Cala Health, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
Boston Scientific Corporation
$16
Silk Road Medical, Inc.
$16
Allergan Inc.
$15
Promius Pharma LLC
$15
Adamas Pharmaceuticals, Inc.
$13
Banner Life Sciences, LLC
$12
Top 3 companies account for 54.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · BAFIERTAM · BIOMONITOR · BRILINTA · Briviact · CALA TRIO · CONFIRM RX · COPAXONE · CREXONT · Cenobamate · DUOPA · EMGALITY · ENROUTE Transcarotid Neuroprotection System · Edarbi · Exablate · FIRDAPSE · Fintepla · Fycompa · GILENYA · GOCOVRI · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEQEMBI · LINQ II · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SYMPAZAN · Soliris · Solitaire · TECFIDERA · TOPIRAMATE Extended Release Capsules · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WATCHMAN FLX · Wakix · Xadago · Zembrace · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
140
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
DELRAY MEDICAL CENTER
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gerstle is a clinical cardiology specialist, with above-average Medicare volume (top 20% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gerstle experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Gerstle performed 542 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gerstle receive payments from pharmaceutical companies?
Yes. Dr. Gerstle received a total of $21,990 from 62 companies across 574 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gerstle's costs compare to other neurologists in Boynton Beach?
Dr. Gerstle's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gerstle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Boynton Beach
Browse neurologists in Boynton Beach ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Amneal Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Amneal Pharmaceuticals LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology